2025-06-08Niranjan Ghatule
As India becomes the fourth-largest economy, are foreign investors shifting focus toward China? This in-depth article explores how global fund managers are positioning their investments, sectoral strategies in Indian markets, and why defense stocks might not be as attractive as they seem.
View more
2025-05-07Niranjan Ghatule
Shares of Aarti Drugs surged 20% to hit the upper circuit at Rs 420 following strong Q4 FY24 results and favorable legal relief. The company reported a sharp rise in revenue and profit continues its Rs 600 crore capex-driven growth journey. With leadership in over 50 API molecules and a robust global footprint, Aarti Drugs is positioned for long-term expansion.
View more
Your experience on this site will be improved by allowing cookies
Cookie Policy
